CIK 0001896212 · <br>Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 873272543
- Phone
- (646) 491 9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- 4 Grant or award Director acquired 29,354 shares (grant or award)
- 4 Grant or award Director acquired 32,022 shares (grant or award)
- 4 Grant or award Director acquired 46,629 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 437,976 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 299,238 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 341,594 shares (grant or award)
- 4 Open-market sale 10% owner sold 3,808,000 shares at an average $0.10 ($393,439)
- 4 Open-market sale 10% owner sold 2,600,000 shares at an average $0.11 ($297,644)
- 4 Open-market sale Director sold 15,301,068 shares at an average $0.30 ($4,592,487)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 37,272 shares (grant or award)
- 4 Grant or award Interim CFO acquired 37,272 shares (grant or award)
- 4 Returned to the company Chief Financial Officer returned 74,545 shares (to the company)
Page 2 of 4 · 67 filings